Medical Weight Loss for Cleveland, Tennessee Residents

Cleveland, Tennessee residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Cleveland through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Start this week from Cleveland: book a video visit, complete your intake, and if you are a fit, your compounded medication ships to your Tennessee door. No travel to California required. Doctor review just $119 (medication separate).

Why Cleveland Residents Choose New Hope Weight Loss

Cost should not be a guessing game, and in Cleveland it is not. Our flat pricing means semaglutide from $166 a month, tirzepatide from $233 a month, and a $119 physician review, with the medication billed separately and nothing buried in fine print. People across Tennessee tell us the relief of simply knowing the number ahead of time is half the reason they finally got started.

Cleveland is served through telehealth from our Costa Mesa, California clinic. The full physician-supervised GLP-1 program runs by secure video, with compounded medication shipped to your Cleveland address.

New Hope Weight Loss is based in Costa Mesa, yet a patient in Cleveland sees the same doctor, takes the same approach, and pays the same prices, all through telehealth across Tennessee. We care for patients throughout downtown Cleveland and the greater Bradley County area of southeast Tennessee. From your first question to your ongoing refills, the whole Tennessee experience is built to feel personal, private, and genuinely supported.

Tirzepatide from $233 per month and semaglutide from $166 per month cost the same whether you are in downtown Cleveland or a rural corner of Tennessee. The 90-day semaglutide program is $499, which works out to a lower monthly cost than paying month to month for many Cleveland patients. Tennessee is one of the fastest-growing states in the South, and New Hope Weight Loss serves patients across it entirely by telehealth from our Costa Mesa, California clinic.

GLP-1 Weight Loss Programs Available

The 90-Day Metabolic Reset (Semaglutide)

Think of this as a focused three-month plan. Semaglutide carries the same active ingredient as Wegovy and Ozempic, and the branded versions averaged about 15 to 17 percent body-weight loss in trials. Pricing is from $166/mo, with the full 90 days at $499, and Dr. Sharma adjusts your dose along the way. Compounded semaglutide is not FDA-approved, not brand-identical, and individual results vary.

Advanced Program (Tirzepatide)

From $233/mo, tirzepatide engages two metabolic pathways, GLP-1 and GIP. Trials of the branded drug reached up to 22.5 percent loss at higher qualifying doses, a best-case figure rather than the norm. Shares an active ingredient with Mounjaro and Zepbound.

Doctor review: $119. Medication billed separately. HSA, FSA, Klarna, and Affirm welcome for Cleveland telehealth patients.

How Telehealth Works for Cleveland

Getting started in Cleveland is simple, and you never have to leave home. Begin with a short intake quiz about your health history, weight goals, and any medications you take. Dr. Anjmun Sharma reviews your answers and meets you by secure video, usually within 48 hours, to talk through whether compounded semaglutide or tirzepatide is a reasonable fit. If she prescribes, a state-licensed 503(a) pharmacy ships your medication straight to your Cleveland address in cold-pack packaging that keeps it stable in transit. From there, your follow-up visits happen by video too, so dose checks and questions stay easy no matter where in you live.

Frequently Asked Questions, Cleveland

Where is the New Hope Weight Loss location serving Cleveland?

The location serving Cleveland is our Costa Mesa, California clinic, which is our only physical site. We care for Cleveland, Tennessee patients through telehealth rather than a local office. Dr. Anjmun Sharma confirms your eligibility for a compounded GLP-1 plan during a private video consult.

Is remote care a real option for Cleveland patients?

It is the standard for Cleveland. The whole program runs on telehealth, so consults, follow-ups, and support happen wherever you are. When Dr. Sharma approves you, compounded medication ships to Cleveland in cold-pack packaging engineered to keep it at a safe temperature in transit.

How much does a Cleveland patient pay overall?

The physician review is $119. Compounded semaglutide is offered from $166 monthly, or $499 for 90 days, and tirzepatide from $233 monthly. The medication is billed separately from the visit. We accept HSA, FSA, Klarna, and Affirm, and we apply no distance surcharge for Cleveland patients.

What areas of Cleveland do you serve?

We serve patients from across Cleveland by telehealth, including downtown Cleveland and the greater Bradley County area of southeast Tennessee.

What makes this different from a local Cleveland medspa or clinic?

A named, licensed physician, Dr. Anjmun Sharma, supervises every case. Contraindications are screened at intake, the 503(a) compounding pharmacy is identified, and pricing is flat and stated up front. Cleveland patients get a real physician-led medical practice by telehealth, not a quick membership sign-up.

Cleveland Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Cleveland, Tennessee by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.